December 8, 2022
FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits
Editor's Note
The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious.
The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19.
The recall was initiated because the kits were distributed to US customers without authorization, clearance, or approval by the FDA.
Distribution dates were May 2020 to January 2022.
Free Daily News
- Report: Medical student distress rises amid overall healthcare burnout improvement
- Prosthetic insurance coverage disparities persist despite legal protections
- Study: GLP-1 drugs reduce surgical complications in diabetes patients
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit
- Healthcare M&A activity set to rebound in 2025 amid stricter state oversight
- High participation in ASCQR program continues, March deadline for reconsideration requests
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management
- Senate report: Private equity endangers patient care in underserved hospitals
- Study: Postoperative thirst often overlooked by OR, ward nurses
- FDA draft guidance addresses pulse oximeter accuracy, AI devices
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement